NextCure, Inc. SEC filings NXTC

NextCure, Inc. has 394 filings in SEC EDGAR's recent list, going back to Jan 11, 2016. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.

NextCure, Inc. SEC filings
Form Description Filed Period
S-4/A Filing Nov 2, 2026 —
8-K Current report
Officer or director change
Oct 30, 2026 Oct 26, 2026
4 Insider transaction Oct 27, 2026 Oct 23, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 20, 2026 —
S-4/A Filing Oct 1, 2026 —
425 Filing Sep 25, 2026 —
8-K Current report
Other events
Sep 25, 2026 Sep 21, 2026
8-K Current report
Material agreement
Sep 3, 2026 Sep 3, 2026
S-4 Registration for a merger or exchange Aug 18, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 12, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
425 Filing Aug 10, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
425 Filing Aug 4, 2026 —
4 Insider transaction Aug 3, 2026 Jul 30, 2026
4 Insider transaction Jul 29, 2026 Jul 27, 2026
3 Initial insider ownership Jul 29, 2026 Jul 27, 2026
425 Filing Jul 16, 2026 —
425 Filing Jul 14, 2026 —
8-K Current report
Material agreement, Exit or restructuring costs, Change in control, Officer or director change, Regulation FD disclosure, Other events
Jul 14, 2026 Jul 14, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 25, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 1, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 18, 2026
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 5, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 12, 2026 —
4 Insider transaction Feb 3, 2026 Jan 30, 2026
4 Insider transaction Feb 3, 2026 Jan 30, 2026
4 Insider transaction Feb 3, 2026 Jan 30, 2026
4 Insider transaction Feb 3, 2026 Jan 30, 2026
4 Insider transaction Feb 3, 2026 Jan 30, 2026
4 Insider transaction Feb 3, 2026 Jan 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 23, 2026 Jan 23, 2026
8-K Current report
Other events
Dec 19, 2025 Dec 19, 2025
424B5 Prospectus supplement Dec 19, 2025 —
EFFECT Filing Dec 11, 2025 —
424B1 Filing Dec 11, 2025 —
D Filing Dec 10, 2025 —
CORRESP Letter to the SEC Dec 9, 2025 —
S-3 Shelf registration Nov 26, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Nov 17, 2025 Nov 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 24, 2025 —
3/A Filing Sep 29, 2025 Jun 20, 2025
8-K Current report
Officer or director change
Aug 25, 2025 Aug 21, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 19, 2025 —
3 Initial insider ownership Aug 19, 2025 Jun 20, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
EFFECT Filing Jul 29, 2025 —
424B2 Prospectus Jul 29, 2025 —
CORRESP Letter to the SEC Jul 28, 2025 —
UPLOAD Letter from the SEC Jul 24, 2025 —
S-3 Shelf registration Jul 18, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jul 14, 2025 Jul 14, 2025
8-K Current report
Other events
Jul 10, 2025 Jul 10, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
8-K Current report
Shareholder vote results
Jun 23, 2025 Jun 20, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Jun 16, 2025 Jun 13, 2025
DEFA14A Additional proxy material May 19, 2025 —
DEFA14A Additional proxy material May 19, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 20, 2025
PRE 14A Preliminary proxy statement Apr 15, 2025 Jun 20, 2025
8-K Current report
Regulation FD disclosure
Apr 10, 2025 Apr 10, 2025
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
3 Initial insider ownership Feb 6, 2025 Feb 1, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
8-K Current report
Listing notice
Feb 3, 2025 Jan 31, 2025
8-K Current report
Other events
Jan 10, 2025 Jan 10, 2025
8-K Current report
Other events
Dec 10, 2024 Dec 10, 2024
8-K Current report
Regulation FD disclosure
Dec 5, 2024 Dec 5, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
8-K Current report
Regulation FD disclosure
Nov 8, 2024 Nov 8, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
SC 13G Ownership over 5% (passive) Jun 27, 2024 —
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
8-K Current report
Shareholder vote results
Jun 21, 2024 Jun 20, 2024
8-K Current report
Officer or director change
Jun 18, 2024 Jun 18, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 20, 2024
PRE 14A Preliminary proxy statement Apr 16, 2024 Jun 20, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
SC 13G Ownership over 5% (passive) Apr 1, 2024 —
10-K Annual report Mar 21, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 21, 2024 Mar 21, 2024
SC 13D/A Amended ownership over 5% (active) Mar 8, 2024 —
4 Insider transaction Feb 1, 2024 Jan 31, 2024
4 Insider transaction Feb 1, 2024 Jan 31, 2024
4 Insider transaction Feb 1, 2024 Jan 31, 2024
4 Insider transaction Feb 1, 2024 Jan 31, 2024
4 Insider transaction Feb 1, 2024 Jan 31, 2024
4 Insider transaction Feb 1, 2024 Jan 31, 2024
4 Insider transaction Feb 1, 2024 Jan 31, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 19, 2024 —
8-K Current report
Regulation FD disclosure
Dec 14, 2023 Dec 14, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
EFFECT Filing Aug 11, 2023 —
CORRESP Letter to the SEC Aug 9, 2023 —
UPLOAD Letter from the SEC Aug 8, 2023 —
S-8 Employee stock plan registration Aug 4, 2023 —
S-3 Shelf registration Aug 4, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Officer or director change
Jul 19, 2023 Jul 15, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 26, 2023 Jun 22, 2023
4 Insider transaction Jun 23, 2023 Jun 22, 2023
4 Insider transaction Jun 23, 2023 Jun 22, 2023
4 Insider transaction Jun 23, 2023 Jun 22, 2023
4 Insider transaction Jun 23, 2023 Jun 22, 2023
4 Insider transaction Jun 23, 2023 Jun 22, 2023
4 Insider transaction Jun 23, 2023 Jun 22, 2023
4 Insider transaction Jun 23, 2023 Jun 22, 2023
4 Insider transaction Jun 23, 2023 Jun 22, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 22, 2023
424B5 Prospectus supplement Apr 4, 2023 —
10-K Annual report Mar 2, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 2, 2023 Mar 2, 2023
4 Insider transaction Mar 1, 2023 Feb 28, 2023
4 Insider transaction Mar 1, 2023 Feb 28, 2023
4 Insider transaction Mar 1, 2023 Feb 28, 2023
4 Insider transaction Mar 1, 2023 Feb 28, 2023
4 Insider transaction Mar 1, 2023 Feb 28, 2023
4 Insider transaction Mar 1, 2023 Feb 28, 2023
4 Insider transaction Mar 1, 2023 Feb 28, 2023
3 Initial insider ownership Feb 28, 2023 Feb 24, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2023 —
SC 13G Ownership over 5% (passive) Jan 24, 2023 —
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
4 Insider transaction Jun 24, 2022 Jun 23, 2022
4 Insider transaction Jun 24, 2022 Jun 23, 2022
4 Insider transaction Jun 24, 2022 Jun 23, 2022
4 Insider transaction Jun 24, 2022 Jun 23, 2022
4 Insider transaction Jun 24, 2022 Jun 23, 2022
4 Insider transaction Jun 24, 2022 Jun 23, 2022
4 Insider transaction Jun 24, 2022 Jun 23, 2022
4 Insider transaction Jun 24, 2022 Jun 23, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NXTC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Baltimore, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1661059

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.